Literature DB >> 27836641

2',3'-Cyclic nucleotide 3'-phosphodiesterase as a messenger of protection of the mitochondrial function during melatonin treatment in aging.

Yulia Baburina1, Irina Odinokova1, Tamara Azarashvili1, Vladimir Akatov1, John J Lemasters2, Olga Krestinina3.   

Abstract

The process of aging is considered to be tightly related to mitochondrial dysfunction. One of the causes of aging is an increased sensitivity to the induction of mitochondrial permeability transition pore (mPTP) opening in the inner membrane of mitochondria. Melatonin, a natural antioxidant, is a hormone produced by the pineal gland. The role of melatonin whose level decreases with aging is well understood. In the present study, we demonstrated that long-term treatment of aged rats with melatonin improved the functional state of mitochondria; thus, the Ca2+ capacity was enhanced and mitochondrial swelling was deaccelerated in mitochondria. Melatonin prevented mPTP and impaired the release of cytochrome c and 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) from mitochondria of both young and aged rats. Our data suggest that melatonin retains СNPase inside mitochondria, thereby providing the protection of the protein against deleterious effects of 2',3'-cAMP in aging. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2′,3′-Cyclic nucleotide 3′-phosphodiesterase; Aging; Melatonin; Permeability transition pore; Rat liver mitochondria

Mesh:

Substances:

Year:  2016        PMID: 27836641      PMCID: PMC5539527          DOI: 10.1016/j.bbamem.2016.11.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  62 in total

Review 1.  Apoptosis in the aging process.

Authors:  Y Higami; I Shimokawa
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

2.  Cytochrome c release from mitochondria in the aging heart: a possible mechanism for apoptosis with age.

Authors:  Sharon Phaneuf; Christiaan Leeuwenburgh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-02       Impact factor: 3.619

3.  Mitochondrial 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNP) interacts with mPTP modulators and functional complexes (I-V) coupled with release of apoptotic factors.

Authors:  Yulia Baburina; Tamara Azarashvili; Dmitry Grachev; Olga Krestinina; Anastasya Galvita; Rolf Stricker; Georg Reiser
Journal:  Neurochem Int       Date:  2015-07-15       Impact factor: 3.921

4.  The brain in vivo expresses the 2',3'-cAMP-adenosine pathway.

Authors:  Jonathan D Verrier; Travis C Jackson; Rashmi Bansal; Patrick M Kochanek; Ava M Puccio; David O Okonkwo; Edwin K Jackson
Journal:  J Neurochem       Date:  2012-03-20       Impact factor: 5.372

Review 5.  Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy.

Authors:  Paula A Witt-Enderby; Nicholas M Radio; John S Doctor; Vicki L Davis
Journal:  J Pineal Res       Date:  2006-11       Impact factor: 13.007

6.  Rat liver mitochondrial damage under acute or chronic carbon tetrachloride-induced intoxication: protection by melatonin and cranberry flavonoids.

Authors:  V T Cheshchevik; E A Lapshina; I K Dremza; S V Zabrodskaya; R J Reiter; N I Prokopchik; I B Zavodnik
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-14       Impact factor: 4.219

7.  Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart.

Authors:  P Anversa; T Palackal; E H Sonnenblick; G Olivetti; L G Meggs; J M Capasso
Journal:  Circ Res       Date:  1990-10       Impact factor: 17.367

8.  How melatonin interacts with lipid bilayers: a study by fluorescence and ESR spectroscopies.

Authors:  E J Costa; C S Shida; M H Biaggi; A S Ito; M T Lamy-Freund
Journal:  FEBS Lett       Date:  1997-10-13       Impact factor: 4.124

Review 9.  Structural and functional evolution of 2',3'-cyclic nucleotide 3'-phosphodiesterase.

Authors:  Matti Myllykoski; Leonie Seidel; Gopinath Muruganandam; Arne Raasakka; Andrew E Torda; Petri Kursula
Journal:  Brain Res       Date:  2015-09-11       Impact factor: 3.252

10.  Interaction of myelin basic protein and 2',3'-cyclic nucleotide phosphodiesterase with mitochondria.

Authors:  Yu L Baburina; A E Gordeeva; D A Moshkov; O V Krestinina; A A Azarashvili; I V Odinokova; T S Azarashvili
Journal:  Biochemistry (Mosc)       Date:  2014-06       Impact factor: 2.487

View more
  10 in total

1.  The Effects of PK11195 and Protoporphyrin IX Can Modulate Chronic Alcohol Intoxication in Rat Liver Mitochondria under the Opening of the Mitochondrial Permeability Transition Pore.

Authors:  Yulia Baburina; Irina Odinokova; Olga Krestinina
Journal:  Cells       Date:  2020-07-24       Impact factor: 6.600

2.  Possible Involvement of 2',3'-Cyclic Nucleotide-3'-Phosphodiesterase in the Protein Phosphorylation-Mediated Regulation of the Permeability Transition Pore.

Authors:  Yulia Baburina; Irina Odinokova; Tamara Azarashvili; Vladimir Akatov; Linda Sotnikova; Olga Krestinina
Journal:  Int J Mol Sci       Date:  2018-11-07       Impact factor: 5.923

3.  Effect of Melatonin on Rat Heart Mitochondria in Acute Heart Failure in Aged Rats.

Authors:  Irina Odinokova; Yulia Baburina; Alexey Kruglov; Irina Fadeeva; Alena Zvyagina; Linda Sotnikova; Vladimir Akatov; Olga Krestinina
Journal:  Int J Mol Sci       Date:  2018-05-23       Impact factor: 5.923

4.  Astaxanthin Inhibits Mitochondrial Permeability Transition Pore Opening in Rat Heart Mitochondria.

Authors:  Yulia Baburina; Roman Krestinin; Irina Odinokova; Linda Sotnikova; Alexey Kruglov; Olga Krestinina
Journal:  Antioxidants (Basel)       Date:  2019-11-21

5.  2',3'-Cyclic-nucleotide 3'-phosphodiesterase contributes to epithelial-mesenchymal transition of lens epithelial cells through the notch signalling pathway.

Authors:  Yue Li; Yu Zhao; Yan Wang
Journal:  Cell Prolif       Date:  2019-10-16       Impact factor: 6.831

Review 6.  Targeting the Mitochondrial Permeability Transition Pore to Prevent Age-Associated Cell Damage and Neurodegeneration.

Authors:  Andrew C Kent; Khairat Bahgat Youssef El Baradie; Mark W Hamrick
Journal:  Oxid Med Cell Longev       Date:  2021-01-28       Impact factor: 6.543

Review 7.  Melatonin as an Anti-Aging Therapy for Age-Related Cardiovascular and Neurodegenerative Diseases.

Authors:  Virna Margarita Martín Giménez; Natalia de Las Heras; Vicente Lahera; Jesús A F Tresguerres; Russel J Reiter; Walter Manucha
Journal:  Front Aging Neurosci       Date:  2022-06-03       Impact factor: 5.702

Review 8.  The Functions of Mitochondrial 2',3'-Cyclic Nucleotide-3'-Phosphodiesterase and Prospects for Its Future.

Authors:  Krestinina Olga; Baburina Yulia; Papadopoulos Vassilios
Journal:  Int J Mol Sci       Date:  2020-05-01       Impact factor: 5.923

9.  Melatonin Can Strengthen the Effect of Retinoic Acid in HL-60 Cells.

Authors:  Olga Krestinina; Roman Fadeev; Alexey Lomovsky; Yulia Baburina; Margarita Kobyakova; Vladimir Akatov
Journal:  Int J Mol Sci       Date:  2018-09-21       Impact factor: 5.923

10.  Astaxanthin Prevents Mitochondrial Impairment Induced by Isoproterenol in Isolated Rat Heart Mitochondria.

Authors:  Olga Krestinina; Yulia Baburina; Roman Krestinin; Irina Odinokova; Irina Fadeeva; Linda Sotnikova
Journal:  Antioxidants (Basel)       Date:  2020-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.